FDA Clearance Tracker · K250652
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
Last checked: Nov 19, 2026Latest source record: Jul 28, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jul 28, 2025
Substantially Equivalent
Time to decision
146 days
Received Mar 4, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250652
- Device name
- ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
- Applicant
- Anumana, Inc.
- Applicant location
- Cambridge, MA
- Received
- Mar 4, 2025
- Decided
- Jul 28, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2380
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QYE. The earliest in FDA's data is K232699, decided Sep 28, 2023.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250652
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Anumana, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- WatchMate Software510(k)
K260300 · Decided Jun 15, 2026 · 136 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
- ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)Breakthrough510(k)
K253801 · Decided Apr 7, 2026 · 130 days after receipt
Device type: Cardiac Amyloidosis Machine Learning-Based Notification Software (SHP) · Cardiology
- ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)Breakthrough510(k)
K252360 · Decided Mar 28, 2026 · 242 days after receipt
Device type: Pulmonary Hypertension Machine Learning-Based Notification Software (SAT) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.